Skip to main content

Publications

32. Meng, P., Dalal, H., Chen, Y., Brueffer, C., Gladchuk, S., Alcaide, M., ... & Saal, L. H. (2024). Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab. npj Breast Cancer, 10(1), 1-10.

31. Meisser, S. S., Mitamura, Y., Altunbulakli, C., Bandier, J., Opstrup, M. S., Gadsbøll, A. S. Ø., ... & Bonefeld, C. M. (2024). Regulation of immune response genes in the skin of allergic and clinically tolerant individuals exposed to p‐phenylenediamine. Allergy.

30. Altunbulakli, C., Jimenez, D. G., Askmyr, D., Sobti, A., Swoboda, S., Greiff, L., & Lindstedt, M. (2023). Targeted spatial proteomic analysis of CD8+ T-and myeloid cells in tonsillar cancer. Frontiers in Oncology, 13.

29. Gerdtsson, A. S., de Matos Rodrigues, J., Eskelund, C. W., Husby, S., Grønbæk, K., Räty, R., ... & Ek, S. (2023). Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established high-risk factors. Haematologica108(4), 1092.

28. Jimenez, D. G.Altunbulakli, C., Swoboda, S., Sobti, A., Askmyr, D., Ali, A., Greiff, L. & Lindstedt, M. (2023). Single-cell analysis of myeloid cells in HPV+ tonsillar cancerFrontiers in Immunology13, 1087843.

27. Kalliara, E., Belfrage, E., Gullberg, U., Drott, K., & Ek, S. (2023). Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell LymphomaCancers15(8), 2362.

26. Mosquim Junior, S., Siino, V., Rydén, L., Vallon-Christersson, J., Levander, L. (2022). Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker DiscoveryCancers, 14(23).

25. Velickovic, K., Borrebaeck, C.A.K., Bendahl, P-O., Hegardt, C., Johnsson, P., Richter, C., Ryden, L., & Hallberg, I. (2022). One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and socio-demographic factors for Health-Related Quality of LifeFrontiers in Oncology, 12.

24. De Alwis, R., Hansson, J., Lindgren, D., Schoch, S., Tejera, A., Scholtz, B., ... & Axelson, H. (2022). Size‑based isolation and detection of renal carcinoma cells from whole bloodMolecular and clinical oncology16(5), 1-11.

23. Siino, V., Ali, A., Accardi, G., Aiello, A., Ligotti, M. E., Mosquim Junior, S., ... & Vasto, S. (2022). Plasma proteome profiling of healthy individuals across the life span in a Sicilian cohort with long‐lived individualsAging Cell21(9), e13684.

22. Boraka, Ö., Klintman, M., & Rosendahl, A. H. (2022). Physical Activity and Long-Term Risk of Breast Cancer, Associations with Time in Life and Body Composition in the Prospective Malmö Diet and Cancer StudyCancers14(8), 1960.

21. Governa, V., Talbot, H., Gonçalves de Oliveira, K., Cerezo-Magaña, M., Bång-Rudenstam, A., Johansson, M. C., ... & Belting, M. (2022). Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization.PNAS119(9), e2114456119.

20. Lopez de Lapuente Portilla, A., Ekdahl, L., Cafaro, C., Ali, Z., Miharada, N., Thorleifsson, G., ... & Nilsson, B. (2022). Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+ cell levelsBlood, The Journal of the American Society of Hematology139(11), 1659-1669.

19. Dalal, H., Dahlgren, M., Gladchuk, S., Brueffer, C., Gruvberger-Saal, S. K., & Saal, L. H. (2022). Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumorsScientific Reports12(1), 1-12.

18. Kopecky, J., Pérez, J. E., Eriksson, H., Visse, E., Siesjö, P., & Darabi, A. (2022). Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functionsScientific Reports12(1), 1–12.

17. Ajore, R., Niroula, A., Pertesi, M., Cafaro, C., Thodberg, M., Went, M., Bao EL, Duran-Lozano, L. ... & Nilsson, B. (2022). Functional dissection of inherited non-coding variation influencing multiple myeloma riskNature Communications, 13(1), 1-15.

16. Lokhande, L., Kuci Emruli, V., Eskelund, C. W., Kolstad, A., Hutchings, M., Räty, R., ... & Ek, S. (2021). Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphomaCancer Reports, e1524.

15. Jimenez, D. G.Sobti, A., Askmyr, D., Sakellariou, C., Santos, S. C., Swoboda, S., ... & Lindstedt, M. (2021). Tonsillar Cancer with High CD8+ T-Cell Infiltration Features Increased Levels of Dendritic Cells and Transcriptional Regulation Associated with an Inflamed Tumor MicroenvironmentCancers13(21), 5341.

14. Sobti, A., Sakellariou, C., Nilsson, M., Schwartz, S., Olofsson, K., Rydell, R., ... & Forslund, O. (2021). Immune delineation of laryngeal papilloma reveals enhanced neutrophil associated gene profileEuropean Journal of Immunology51(10), 2535-2539.

13. Merrien, M., Wasik, A. M., Ljung, E., Morsy, M. H., de Matos Rodrigues, J., Carlsten, M., ... & Sander, B. (2021). Clinical and biological impact of SAMHD1 expression in mantle cell lymphomaVirchows Archiv, 1-12.

12. Askmyr, D., Abolhalaj, M., Jimenez, D. G., Greiff, L., Lindstedt, M., & Lundberg, K. (2021). Pattern recognition receptor expression and maturation profile of dendritic cell subtypes in human tonsils and lymph nodesHuman Immunology82(12), 976-981.

11. Mukherjee, S., Sundfeldt, K., Borrebaeck, C. A., & Jakobsson, M. E. (2021). Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease BiomarkersProteomes9(2), 25.

10. Duran-Lozano, L., Thorleifsson, G., de Lapuente Portilla, A. L., Niroula, A., Went, M., Thodberg, M., ... & Nilsson, B. (2021). Germline variants at SOHLH2 influence multiple myeloma riskBlood cancer journal11(4), 1-8.

9.  Rodrigues, J. M., Porwit, A., Hassan, M., Ek, S., & Jerkeman, M. (2021). Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targetsLeukemia & Lymphoma, 1-11.

8. Rodrigues, J.M., Nikkarinen, A., Hollander, P., Weibull, C.E., Räty, R., Kolstad, A., Amini, R.M., Porwit, A., Jerkeman, M., Ek, S. and Glimelius, I., 2021. Infiltration of CD163-, PD-L1-and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factorsBritish Journal of Haematology93(3), 520-531.

7. Lokhande, L., Emruli, V. K., Kolstad, A., Hutchings, M., Räty, R., Jerkeman, M., & Ek, S. (2020). Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on riskBMC cancer20(1), 1-13.

6. Nilsson, J. S., Sobti, A., Swoboda, S., Erjefält, J. S., Forslund, O., Lindstedt, M., & Greiff, L. (2020). Immune Phenotypes of Nasopharyngeal Cancer. Cancers12(11), 3428.

5. Gomez Jimenez, D., Carreira Santos, S., Greiff, L., Alm, K., & Lindstedt, M. (2020). Subpopulations of Organoid-Forming Cells Have Different MotilityApplied Sciences10(13), 4673.

4. Rodrigues, J. M., Hassan, M., Freiburghaus, C., Eskelund, C. W., Geisler, C., Räty, R., ... & Kwiecinska, A. (2020). p53 is associated with high‐risk and pinpoints TP53 missense mutations in mantle cell lymphoma. British Journal of Haematology.

3. Ramakrishnan, R., Peña-Martínez, P., Agarwal, P., Rodriguez-Zabala, M., Chapellier, M., Högberg, C., ... & Nilsson, B. (2020). CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid LeukemiaCell Reports31(8), 107684.

2. Velickovic, K., Rahm Hallberg, I., Axelsson, U., Borrebaeck, C. A., Rydén, L., Johnsson, P., & Månsson, J. (2020). Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in SwedenHealth and Quality of Life Outcomes18, 1-10.

1. Pérez, J. E., Kopecky, J., Visse, E., Darabi, A., & Siesjö, P. (2020). Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomasBMC cancer20(1), 1-12.

Page Manager: jana.hagman@immun.lth.se | 2023-09-11